Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novavax Inc NVAX

Healthcare Biotechnology
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID... see more

Recent & Breaking News (NDAQ:NVAX)

World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine

PR Newswire December 21, 2021

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novavax, Inc. Investors With Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX

PR Newswire December 21, 2021

NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc.

Newsfile December 20, 2021

World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine

PR Newswire December 20, 2021

European Commission Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

PR Newswire December 20, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Jan. 11th Deadline in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys

Newsfile December 20, 2021

Novavax Receives Positive European Medicines Agency Recommendation for Conditional Marketing Authorization of its COVID-19 Vaccine

PR Newswire December 20, 2021

Rosen, A Leading Law Firm, Encourages Novavax, Inc. Investors with Losses to Secure Counsel Before Important January 11 Deadline in Securities Class Action - NVAX

Newsfile December 18, 2021

NVAX Investors Have Opportunity to Lead Novavax, Inc. Securities Fraud Lawsuit

PR Newswire December 17, 2021

Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine

PR Newswire December 17, 2021

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Novavax, Inc. - NVAX

PR Newswire December 16, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Novavax, Inc. of Class Action Lawsuit and Upcoming Deadline - NVAX

Newsfile December 16, 2021

Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine

PR Newswire December 15, 2021

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Novavax, Inc.

Newsfile December 15, 2021

NOVAVAX SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc. - NVAX

PR Newswire December 15, 2021

NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc.

Newsfile December 15, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Lead Plaintiff Opportunity in Securities Class Action, Encourages Investors with Losses to Contact Firm's Attorneys

Newsfile December 15, 2021

NVAX Investor Alert: Thornton Law Firm Reminds Novavax, Inc. Investors of Securities Class Action Lawsuit

Newsfile December 15, 2021

Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Novavax, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm

PR Newswire December 14, 2021

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Novavax, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - NVAX

PR Newswire December 14, 2021